Caprock Group, Inc. Ani Pharmaceuticals Inc Transaction History

Caprock Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 23, 2018	SELL	$56.38 - $68.08 $260,757 - $314,870	-4,625 Closed	0 $0
Q4 2017 Jan 17, 2018	BUY	$53.3 - $74.56 $13,858 - $19,385	260 Added 5.96%	4,625 $334,000
Q3 2017 Oct 23, 2017	BUY	$43.46 - $52.49 $189,702 - $229,118	4,365	4,365 $229,000

211

19.2M

3.4K

10.8K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $968M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.